• Citer

Coverage with evidence development program on stereotactic body radiotherapy in Belgium (2013–2019): a nationwide registry-based prospective study

par Lievens, Yolande;Janssens, Sharon;Lambrecht, Maarten;Engels, Hilde;Geets, Xavier;Jansen, Nicolas;Moretti, Luigi ;Remouchamps, Vincent;Roosens, Sander;Stellamans, Karin;Verellen, Dirk;Weltens, Caroline;Weytjens, Reinhilde;Van Damme, N.
Référence The Lancet Regional Health - Europe, 44, 100992
Publication Publié, 2024-07-06

Article révisé par les pairs

• Accès en ligne
• Détails
• Contenu
• Statistiques

Titre:	Coverage with evidence development program on stereotactic body radiotherapy in Belgium (2013–2019): a nationwide registry-based prospective study
Auteur:	Lievens, Yolande; Janssens, Sharon; Lambrecht, Maarten; Engels, Hilde; Geets, Xavier; Jansen, Nicolas; Moretti, Luigi; Remouchamps, Vincent; Roosens, Sander; Stellamans, Karin; Verellen, Dirk; Weltens, Caroline; Weytjens, Reinhilde; Van Damme, N.
Informations sur la publication:	The Lancet Regional Health - Europe, 44, 100992
Statut de publication:	Publié, 2024-07-06
Sujet CREF:	Cancérologie
Mots-clés:	Coverage with evidence development
	Implementation
	Innovation
	Radiotherapy
	Real-world data
	Stereotactic body radiotherapy
Note générale:	SCOPUS: ar.j
Langue:	Anglais
Identificateurs:	urn:issn:2666-7762
	info:doi/10.1016/j.lanepe.2024.100992
	info:pii/S2666776224001595
	info:scp/85197533169